David C. Myles sold $3.1M of Olema Pharmaceuticals (OLMA)

Executed Jan 12, disclosed Jan 14, 2 days later.

Value, as filed

$3.1M

109,800 sh across 4 lots

Executed

Jan 12

the trade date, as filed

Disclosed

Jan 14

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DM David C. Myles CH. DISCOV. & NON-CLIN DEV OFF profile →

David C. Myles (CH. DISCOV. & NON-CLIN DEV OFF) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Olema Pharmaceuticals, Inc. (OLMA). The largest single filing was $3.1M of OLMA (109,800 sh across 4 lots, as filed), executed Jan 12.

The name

OLMA Olema Pharmaceuticals, Inc. OLMA · Healthcare · 17 filings in 24 months ticker →

Healthcare · Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David C. Myles in OLMA

OLMASALE Olema Pharmaceuticals, Inc. $1.5M
49,775 sh across 2 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. $232K
25,766 sh across 2 lots
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET